Severe interstitial pneumonitis associated with infliximab therapy

Scand J Rheumatol. 2004;33(4):276-7. doi: 10.1080/03009740410005836.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Dyspnea / etiology
  • Female
  • Humans
  • Infliximab
  • Lung Diseases, Interstitial / chemically induced*
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / pathology

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab